HD-OPM Archive
Topics › Inflammation & CRP

Mergen and Hasselbalch review heart drugs, supplements and lifestyle in polycythemia vera

Gokhan Can · Jun 11, 2026 · ♥ 40 reactions · 11 comments · original Facebook post
Inflammation & CRPSupplements & vitamins
AI summary & key facts

The admin announces a March 2026 Frontiers in Hematology paper with Dr Hasselbalch after five years of research. It analyses how cardiovascular drugs, supplements and lifestyle can be used in polycythemia vera and related blood disorders, and the links between cardiovascular disease, chronic inflammation and blood stem cell mutations.

After five years of extensive research, I am proud to share that Dr. Hasselbalch and I have published our latest article in Frontiers in Hematology this March. Our paper provides a comprehensive analysis of how cardiovascular drugs, dietary supplements, and lifestyle interventions can be leveraged to treat Polycythemia Vera and related blood disorders. In this work, we take a deep dive into the complex, underlying connections between cardiovascular disease, chronic inflammation, and blood stem cell mutations.

Paper · Front. Hematol. · 2026Revisiting old drugs and drug combinations for polycythemia vera and related neoplasmsPolycythemia Vera (PV) and related myeloproliferative neoplasms (MPNs) require long-term management to minimize thrombotic complications, disease progression, and improve quality of life. While interferon-alpha (IFN- α ) offers disease-modifying potential, disease symptoms and side effects often persist, necessitating the exploration of complementary therapeutic strategies. This review examines established drugs and…frontiersin.org

Research cited

#supplements#cardiovascular#cardiovasculardisease#stemcells#inflammation
← newer: Epigenome editing could one day silence PCSK9 and treat otheolder: JAMA Cardiology trial: vitamin K2 (MK-7) for 2 years slowed →